In oncology, the key to success lies in the ongoing development and improvement of therapies. Clinical trials meet this requirement and offer participating patients the best treatment according to the current state of science. The particularly detailed study investigations and the careful continuous monitoring of the treatment success represent an increase in the quality of life for participating patients.

The newly introduced structure results in direct advantages for participating study sites:

Access to cooperating study groups and partners from industry

Access to current trials carried out in Austria according to the latest state of science

Possibility to contribute your own trial ideas and implement them with appropriate support – also for international study groups

Reduced administrative effort, so that the focus of the study sites can be on the conduct of trials

There is also a significant benefit for patients:

Access to new therapies according to the latest Austrian and international standards

Publication of results from current clinical research and establishment of better treatments and innovative therapy standards